532167 — Omkar Pharmachem Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹225.90m
- IN₹230.00m
- IN₹5.40m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.203 | 0.408 | 0.439 | 2.11 | 1.33 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 0.18 | 0.27 | 0.81 | 1.3 |
Total Current Assets | 0.203 | 0.588 | 0.709 | 2.92 | 2.62 |
Net Property, Plant And Equipment | 0.03 | 0.025 | 0.015 | 0.064 | 0.037 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 93.2 | 93.6 | 96.3 | 98.3 | 97.3 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.23 | 9.21 | 9.68 | 9.84 | 6.86 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 6.23 | 9.21 | 9.68 | 9.84 | 6.86 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 87 | 84.4 | 86.6 | 88.5 | 90.4 |
Total Liabilities & Shareholders' Equity | 93.2 | 93.6 | 96.3 | 98.3 | 97.3 |
Total Common Shares Outstanding |